Here To Push
The Boundaries
Of Science
Clinical Trials Now Enrolling
The CLARITY-FA natural history study is designed for researchers to learn about how heart disease develops and worsens in individuals with FA.
About Us
At Lexeo, we strive to redefine the possibilities for treatment of genetic heart diseases using pioneering science and precise approaches. By delivering a functional (correct) copy of the gene to the heart, we aim to provide a lasting, potentially disease-curing solution.
We hope this science excites you as much as it does us!
Scroll down to learn more about how we tackle genetic diseases at their heart.
Our pipeline primarily focuses on investigational gene therapies targeting genetic diseases that impact the heart — which can lead to devastating outcomes. Currently, we are conducting investigational gene therapy trials in Friedreich ataxia cardiomyopathy (FA-CM) and arrhythmogenic cardiomyopathy (ACM).
Keep reading to learn more about investigational gene therapy and how it works.
Our Approach
Researchers and scientists have made exciting strides to better understand and use gene therapy to tackle genetic diseases.
The goal of investigational gene therapy is to help treat or prevent diseases by targeting the underlying cause — a gene that is not working correctly.
